Drouet L - Search Results

1

Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?

Drouet L, Bal Dit Sollier C, Steiner T, Purrucker J. Drouet L, et al. Int J Stroke. 2016 Oct;11(7):748-58. doi: 10.1177/1747493016659671. Epub 2016 Jul 13. Int J Stroke. 2016. PMID: 27412190 Review.

2

Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.

Zhang Q, Bal-dit-Sollier C, Drouet L, Simoneau G, Alvarez JC, Pruvot S, Aubourg R, Berge N, Bergmann JF, Mouly S, Mahé I. Zhang Q, et al. Among authors: drouet l. Eur J Clin Pharmacol. 2011 Mar;67(3):309-14. doi: 10.1007/s00228-010-0975-2. Epub 2010 Dec 30. Eur J Clin Pharmacol. 2011. PMID: 21191575 Clinical Trial.

3

Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial.

Zhang Q, Simoneau G, Verstuyft C, Drouet L, Bal dit Sollier C, Alvarez JC, Rizzo-Padoin N, Bergmann JF, Becquemont L, Mouly S. Zhang Q, et al. Among authors: drouet l. Br J Clin Pharmacol. 2011 Feb;71(2):232-6. doi: 10.1111/j.1365-2125.2010.03824.x. Br J Clin Pharmacol. 2011. PMID: 21219403 Free PMC article. Clinical Trial.

4

Enoxaparin chains stored during chronic treatment are mobilized by a bolus of unfractionated heparin: insights from the STACKENOX study.

Bal Dit Sollier C, Berge N, Drouet L. Bal Dit Sollier C, et al. Among authors: drouet l. Blood Coagul Fibrinolysis. 2016 Oct;27(7):779-785. doi: 10.1097/MBC.0000000000000489. Blood Coagul Fibrinolysis. 2016. PMID: 26720847 Clinical Trial.

5

Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.

Dillinger JG, Si Moussi T, Berge N, Bal Dit Sollier C, Henry P, Drouet L. Dillinger JG, et al. Among authors: drouet l. Thromb Res. 2016 Apr;140:66-72. doi: 10.1016/j.thromres.2016.02.006. Epub 2016 Feb 20. Thromb Res. 2016. PMID: 26901852

6

[Which place remains for VKA?].

Bal Dit Sollier C, Dillinger JG, Drouet L. Bal Dit Sollier C, et al. Among authors: drouet l. Rev Prat. 2020 Feb;70(2):123-126. Rev Prat. 2020. PMID: 32877118 French. No abstract available.

7

Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.

Drouet L, Bal dit Sollier C, Martin J. Drouet L, et al. Am Heart J. 2009 Aug;158(2):177-84. doi: 10.1016/j.ahj.2009.05.022. Am Heart J. 2009. PMID: 19619692 Clinical Trial.

8

Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events.

Drouet L, Bal Dit Sollier C. Drouet L, et al. Eur J Clin Invest. 2005 Mar;35 Suppl 1:21-6. doi: 10.1111/j.0960-135X.2005.01453.x. Eur J Clin Invest. 2005. PMID: 15701144 Review.

9

[Monitoring of anticoagulant treatment in patients with cancer].

Mahé I, Bosquet A, Medjkane A, Bal dit Sollier C, Drouet L. Mahé I, et al. Among authors: drouet l. Pathol Biol (Paris). 2008 Jun;56(4):239-44. doi: 10.1016/j.patbio.2008.02.011. Epub 2008 Apr 14. Pathol Biol (Paris). 2008. PMID: 18407438 French.

10

Anticoagulant activity and pleiotropic effects of heparin.

Bal Dit Sollier C, Dillinger JG, Drouet L. Bal Dit Sollier C, et al. Among authors: drouet l. J Med Vasc. 2020 May;45(3):147-157. doi: 10.1016/j.jdmv.2020.03.002. Epub 2020 Apr 17. J Med Vasc. 2020. PMID: 32402428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters